Navigation Links
AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
Date:4/24/2008

WESTCHESTER, Ill., April 24 /PRNewswire/ -- AANS/CNS Section on Tumors and BrainLAB today announced the winner of the 2008 International Research Fellowship. Xiang Wang, MD, from the People's Republic of China, was awarded the fellowship for his proposal, "The Trafficking of Bone Marrow Derived Mesenchymal Stem Cells in Brain Tumor Angiogenesis and Stromal Development."

Dr. Wang will receive a $50,000 stipend to conduct research in his proposed field of study in the laboratory of Victor C-K Tse, MD, PhD, Associate Professor of Neurosurgery at Stanford University. The program will last for one year.

Started in 2006, the fellowship enables international neurosurgeons or graduating residents from outside the United States and Canada to perform clinical, translational or basic research in the field of neurosurgical oncology in a clinical or laboratory setting within the United States. Applications for the 2008 fellowship were received from Brazil, China, Honduras, India, Iran, Italy, Japan, Nigeria and Turkey.

The goal of the fellowship is to foster collaborative research between the U.S. and international neurosurgeons. BrainLAB funds the fellowship through an educational grant and the program receives further support from dedicated U.S. institutions (Investigators), which provide the space and supplies for the applicant during the study period. The winner of the 2007 fellowship, Kazuhiko Kurozumi, MD, from Okayama, Japan, is currently at The Ohio State University laboratory of E. Antonio Chiocca, MD, PhD.

Dr. Kurozumi recently had his paper, "Effect of Tumor Micro-environment Modulation on the Efficacy of Oncolytic Virus Therapy," published in The Journal of the National Cancer Institute (JNCI 99:1768-81, 2007). His fellowship will be completed in June 2008.

According to Michael McDermott, MD, chairman of the AANS/CNS Section on Tumors, "Partnering with BrainLAB for this fellowship is a valuable contribution to the field of neuro-oncology. We hope to continue this collaborative effort for many years as we work together to make critical advances in the diagnosis and treatment of CNS tumors."

"BrainLAB is pleased to partner again this year with the AANS/CNS Section on Tumors on the International Fellowship," said Paolo Jelmoni, Director of Marketing North America, BrainLAB. "The benefits of collaboration between foreign and domestic medical leaders are infinite. We look forward to Dr. Wang's contributions and are honored to play a part in presenting him with this opportunity."

For more information on the fellowship, application procedures and a list of host institutions, visit http://www.tumorsection.org, or contact the Development Department of AANS at +1 (847) 378-0500 or jaq@aans.org.

About AANS

Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 7,200 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurosurgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the spinal column, spinal cord, brain and peripheral nerves.

For more information, visit http://www.aans.org.

About CNS

The Congress of Neurological Surgeons (CNS) is an international neurosurgical association, which has existed since 1951. The purpose of the organization is to enhance health and improve lives worldwide through the advancement of education and scientific exchange. The CNS maintains its vitality via the volunteer efforts of its members, promoting leadership in service to the public and to our colleagues in other disciplines, and to the special needs of our fellow neurosurgeons throughout the world and at every stage of their professional lives.

Members of the CNS include neurosurgeons in-training, board-eligible, and board certified physicians from the United States and other countries. Through active membership, research, advocacy and continuing medical education, the CNS is dedicated to advancing the field of Neurosurgery.

For more information, visit http://www.cns.org.

About BrainLAB

BrainLAB develops, manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and also less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. BrainLAB solutions allow expansion from a single system to operating suites to digitally integrated hospitals covering all subspecialties from neurosurgery, orthopedics, ENT, CMF to spine & trauma and oncology.

With more than 3,000 systems installed in over 70 countries, BrainLAB is a market leader in image-guided technology. The privately held BrainLAB group, founded in 1989, is headquartered in Munich, Germany, and today employs 1,000 people in 16 offices across Europe, Asia, Australia, North and South America.

For more information, visit BrainLAB at http://www.brainlab.com.


'/>"/>
SOURCE BrainLAB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners
2. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
3. Inverness Medical Innovations Announces First Quarter 2008 Results
4. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
5. United Therapeutics to Announce First Quarter 2008 Financial Results Before Market Open on Thursday, May 1, 2008
6. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
7. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
8. Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
9. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
10. Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings
11. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):